Cargando…
Utilizing a Dynamical Description of IspH to Aid in the Development of Novel Antimicrobial Drugs
The nonmevalonate pathway is responsible for isoprenoid production in microbes, including H. pylori, M. tuberculosis and P. falciparum, but is nonexistent in humans, thus providing a desirable route for antibacterial and antimalarial drug discovery. We coordinate a structural study of IspH, a [4Fe-4...
Autores principales: | Blachly, Patrick G., de Oliveira, César A. F., Williams, Sarah L., McCammon, J. Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868525/ https://www.ncbi.nlm.nih.gov/pubmed/24367248 http://dx.doi.org/10.1371/journal.pcbi.1003395 |
Ejemplares similares
-
Use of
Broken-Symmetry Density Functional Theory To
Characterize the IspH Oxidized State: Implications for IspH Mechanism
and Inhibition
por: Blachly, Patrick G., et al.
Publicado: (2014) -
Broken-Symmetry DFT Computations for the Reaction
Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria
por: Blachly, Patrick G., et al.
Publicado: (2015) -
IspH–RPS1 and IspH–UbiA: “Rosetta stone” proteins
por: Rao, Guodong, et al.
Publicado: (2015) -
Insights
into the Binding of Pyridines to the Iron–Sulfur
Enzyme IspH
por: Span, Ingrid, et al.
Publicado: (2014) -
IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance
por: Singh, Kumar Sachin, et al.
Publicado: (2021)